Dupont De Nemours Inc
NYSE:DD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.21
84.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Dupont De Nemours Inc
Dupont De Nemours Inc
Free Cash Flow
Dupont De Nemours Inc
Free Cash Flow Peer Comparison
SHW
IFF
DNA
ECL
PPG
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Free Cash Flow
$1.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Free Cash Flow
$2.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Free Cash Flow
$987m
|
CAGR 3-Years
2%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
|
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
Free Cash Flow
-$336.3m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Free Cash Flow
$2.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Free Cash Flow
$1.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
See Also
What is Dupont De Nemours Inc's Free Cash Flow?
Free Cash Flow
1.2B
USD
Based on the financial report for Jun 30, 2024, Dupont De Nemours Inc's Free Cash Flow amounts to 1.2B USD.
What is Dupont De Nemours Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
14%
Over the last year, the Free Cash Flow growth was 340%. The average annual Free Cash Flow growth rates for Dupont De Nemours Inc have been -20% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
